LUMOS PHARMA, INC. Annual Share-based Payment Arrangement, Expense in USD from 2010 to 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Lumos Pharma, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2010 to 2023.
- Lumos Pharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $379K, a 32.2% decline year-over-year.
- Lumos Pharma, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $1.87M, a 21.6% decline year-over-year.
- Lumos Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $2.32M, a 0.09% increase from 2022.
- Lumos Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $2.32M, a 19.4% decline from 2021.
- Lumos Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.88M, a 168% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)